3 3 3 3 3 3 33
tal Hygienist 9th Edition
3 3 3 3
by Elena Bablenis Haveles, Chapters 1 - 26
3 3 3 3 3 3 3 3
,MULTIPLE 7yCHOICE
1. Knowledge 7yof 7ypharmacology 7yaids 7ythe 7ydental 7yprofessional 7yin
a. obtaining 7ya 7ypatient’s 7yhealth 7yhistory.
b. administering 7ydrugs 7yin 7ythe 7yoffice.
c. handling 7yemergency 7ysituations.
d. selection 7yof 7ya 7ynonprescription
medication.
7y
e. All 7yof 7ythe 7yabove.
ANSWER: 7 y E
All 7yof 7ythe 7ychoices 7yare 7ytrue. 7yBecause 7ymany 7yof 7your 7ypatients 7yare3being 7ytreated 7ywith 7ydrugs,
7yknowledge 7yof 7ypharmacology 7yhelps 7yin 7yunderstanding3and 7yinterpreting 7ypatients’ 7yresponses 7yto
7yhealth 7yhistory 7yquestions. 7yKnowledge 7yof 7ythe 7ytherapeutic 7yand 7yadverse 7yeffects 7yof 7ymedications
7yobviously 7yhelps 7yin 7ytheir 7yproper 7yadm 7yinistration 7yin 7ythe 7yoffice. 7yEmergency 7ysituations 7ymay
7ybe 7ycaused 7yby 7ydrugs 7yor 7ytreated 7yby 7ydrugs; 7ythus, 7ykno 7ywledge 7yof 7ypharmacology 7yis 7yof 7ygreat
7yhelp, 7yespecially 7ybecause 7ya 7yrapid 7yresponse 7yis 7ysometimes 7yrequired. 7yA 7yclear3understanding 7yof
7ythe 7yconcepts 7yof 7ydrug3action, 7ydrug 7yhandling 7yby 7ythe 7ybody, 7yand 7ydrug3interaction 7ys 7ywill 7yallow
7ythe 7ydental 7ypractitioner 7yto 7ymake 7yproper3judgments 7yand 7ygrasp 7ythe 7yconcepts 7yrelevant 7yto 7ynew
7ydrug 7ytherapies 7yon 7ythe 7ymarket.
DIF: 7 y 7 y Application
REF: 7 y Role 7yof 7ythe 7yDental 7yHygienist 7y(Medication/Health 7yHistory), 7yRole 7yof 7ythe 7yDental
7yHygienist 7y(Medicatio 7yn 7yAdministration), 7yRole 7yof 7ythe 7yDental 7yHygienist 7y(Emergency
7ySituations), 7yRole 7yof 7ythe 7yDental 7yHygienist 7y(N 7yonprescription 7yMedication) 7y| 7ypp. 7y2-3 OBJ:
1
TOP: 7 y NBDHE, 7y6.0. 7yPharmacology
2. Which 7yof 7ythe 7yfollowing 7ystatements 7yis 7ytrue 7yregarding 7yplanning3appointments?
a. Whether 7yor 7ynot 7ypatients 7yare 7ytaking 7ymedication 7yfor 7ysystemic 7ydiseases
is 7yof 7ylittle
7y
consequence 7yin 7ythe 7ydental 7yoffice.
b. Asthmatic 7ypatients 7yshould 7yhave 7ydental 7yappointments 7yin 7ythe 7ymorning.
c. Diabetic 7ypatients 7yusually 7yhave 7yfewer 7yproblems 7ywith 7ya 7ymorning
7yappointment
compared 7ywith 7yafternoon 7yappointments.
d. Both 7yB 7yand 7yC 7yare 7ytrue.
ANSWER: 7 y D
Asthmatic 7ypatients 7ywho 7yexperience 7ydental 7yanxiety 7yshould 7yschedule 7ytheir 7yappointments 7ywhen
7ythey 7yare 7yn 7yot 7yrushed 7yor 7yunder 7ypressure 7yearly 7yin 7ythe 7ymorning. 7yDiabetic 7ypatients 7yusually
7yhave 7yrelatively 7yfewer 7yprob 7ylems 7ywith 7ya 7ymorning 7yappointment. 7yPatients 7ytaking 7ymedication
7yfor3systemic 7ydiseases 7ymay 7yrequire 7yspeci 7yal 7yhandling 7yin 7ythe 7ydental 7yoffice.
,DIF: Comprehension
REF: 7 y Role 7yof 7ythe 7yDental 7yHygienist 7y(Appointment
7yScheduling) 7y| 7yp. 7y3 7yOBJ: 7 y 1 TOP: 7 y NBDHE, 7y6.0.
7yPharmacology
, 3. Nutritional 7yor 7yherbal 7ysupplements
a. carry7ythe 7yU.S. 7yFood 7yand 7yDrug 7yAdministration 7y(FDA) 7yapproval 7yfor
disease 7ystates.
7y
b. are 7ynot 7ydrugs.
c. can 7ycause 7yadverse 7yeffects.
d. will 7ynot 7yinteract 7ywith 7yother3drugs 7ythe 7ypatient 7ymay 7ybe 7ytaking.
ANSWER: 7 y C
Nutritional 7yor 7yherbal 7ysupplements 7yare 7yquite 7ycapable 7yof 7ycausing 7yadverse 7yeffects. 7yThe
7ymajority 7yof 7ynutritional 7yor 7yherbal 7ysupplements 7ydo 7ynot 7ycarry 7yFDA 7yapproval 7yfor
7ytreating 7ydisease 7ystates. 7yThese 7ysupplements 7yare 7ydrugs 7yand 7ycan 7ycause 7yadverse 7yeffects
7yand 7yinteract 7ywith 7ydifferent 7ydrugs.
DIF: 7 y 7 y Comprehension
REF: 7 y Role 7yof 7ythe 7yDental 7yHygienist 7y(Nutritional 7yor 7yHerbal
7ySupplements) 7y| 7yp. 7y3 7yOBJ: 7 y 1 TOP: 7 y NBDHE, 7y6.0.
7yPharmacology
4. Which 7ytype 7yof 7ydrug 7yname 7yusually 7ybegins 7ywith 7ya 7ylowercase 7 yletter?
a. Brand 7yname
b. Code 7yname
c. Generic
name
7y
d. Trade 7yname
ANSWER: 7 y C
Before 7yany 7ydrug 7yis 7ymarketed, 7yit 7yis 7ygiven 7ya 7ygeneric 7yname 7ythat 7ybecomes 7ythe 7y“official”
7yname 7yof 7ythe 7ydrug. 7yEach 7ydrug 7yis 7yassigned 7yonly 7yone 7ygeneric 7yname 7yselected 7yby 7ythe 7yU.S.
7yAdopted 7yName 7yCouncil, 7yand 7ythe 7yna 7yme 7yis 7ynot3capitalized. 7yThe 7ybrand 7yname 7yis 7yequivalent
7yto 7ythe 7ytrade 7yname 7yand 7yis 7ycapitalized. 7yAlthough 7ythe 7ybrand 7yname 7yis 7ytechnically 7ythe 7yname
7yof 7ythe 7ycompany 7ymarketing 7ythe 7yproduct, 7ythis 7yterm 7yis 7yoften 7yused 7yinte 7yrchangeably 7ywith 7ythe
7ytrade 7yname. 7yThe 7ycode 7yname 7yis 7ythe 7yinitial 7yterm 7yused 7ywithin 7ya 7ypharmaceutical 7ycom 7ypany
7yto 7yrefer 7yto 7ya 7ydrug 7ywhile 7yit 7yis 7yundergoing 7yinvestigation 7yand 7yis 7yoften 7ya 7ycombination 7yof
7ycapital 7yletter 7ys 7yand 7ynumbers, 7ythe 7yletters 7yrepresenting 7yan 7yabbreviation 7yof 7ythe 7ycompany
7yname.
DIF: Comprehension
REF: 7 y Drug 7yNames 7y| 7yp. 7y4
7yOBJ: 7 y 3 7yTOP: 7 y NBDHE, 7y6.0.
7yPharmacology
5. A 7ydrug’s 7ygeneric 7yname 7yis 7yselected 7yby7ythe
a. pharmaceutical 7ycompany 7ymanufacturing
it.
7y
b. Food 7yand 7yDrug 7yAdministration 7y(FDA).
c. U.S. 7yAdopted 7yName 7yCouncil.
d. Federal 7yPatent 7yOffice.
ANSWER: 7 y C